Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 126 matching records.
126 results — page 1 of 6
- Level DAnimal StudyPubMed
Treatment with Neuronal-Induced Human Mesenchymal Stem Cells Improves Functional Recovery of Acute Spinal Cord Injury through Attenuating Astrogliosis and Neurotoxic Astrocyte Activation.
Animal Study on Spinal Cord Injury, published in J Korean Neurosurg Soc (2026) — summary generated from the PubMed abstract.
- 2026
J Korean Neurosurg Soc - Level BClinical TrialEurope PMC
Mesenchymal stem cells and the central nervous system: historical perspectives and future directions
Clinical Trial on Disc Degeneration, Stroke Research, Spinal Cord Injury, Neuroinflammation, published in Front Mol Neurosci (2026) — summary generated from the PubMed abstract.
- 2026
Front Mol Neurosci1 citations - Level BRandomized Controlled TrialPubMed
Enhancing Lumbar Spinal Fusion Using Hypoxia Preconditioned Culture-Expanded Adipose-Derived Mesenchymal Stem Cells: Evidence From a Rat Posterolateral Lumbar Spinal Fusion Model.
Randomized Controlled Trial on Back & Spine, published in Neurosurgery (2026) — summary generated from the PubMed abstract.
- 2026
Neurosurgery - Level DNarrative ReviewEurope PMC
Current status and future prospects of functionalized mesenchymal stem cells for the treatment of spinal cord injury
Narrative Review on Spinal Cord Injury, Chronic Inflammation, published in J Orthop Translat (2026) — summary generated from the PubMed abstract.
- 2026
J Orthop Translat - Level DAnimal StudyPubMed
Additional benefits of combined ceftriaxone and adipose-derived mesenchymal stem cells on revamping the outcomes in rodent after acute spinal infection.
Animal Study on Face & Skin, Back & Spine, Systemic / IV, published in J Mol Histol (2025) — summary generated from the PubMed abstract.
- 2025
J Mol Histol - Level BClinical TrialEurope PMC
Effects of Combined Intrathecal Mesenchymal Stem Cells and Schwann Cells Transplantation on Neuropathic Pain in Complete Spinal Cord Injury: A Phase II Randomized Active-Controlled Trial
Clinical Trial on Spinal Cord Injury, published in Cell Transplant (2025) — summary generated from the PubMed abstract.
- 2025
Cell Transplant8 citations - Level DNarrative ReviewEurope PMC
Pyroptosis: candidate key targets for mesenchymal stem cell-derived exosomes for the treatment of bone-related diseases
Narrative Review on Osteoarthritis, Spinal Cord Injury, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther7 citations - Level DAnimal StudyPubMed
Administration of hypoxic pretreated adipose-derived mesenchymal stem cell exosomes promotes spinal cord repair after injury via delivery of circ-Astn1 and activation of autophagy.
Animal Study on Spinal Cord Injury, published in Int Immunopharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Int Immunopharmacol3 citations - Level DAnimal StudyEurope PMC
Combined Transplantation of Mesenchymal Progenitor and Neural Stem Cells to Repair Cervical Spinal Cord Injury
Animal Study on Spinal Cord Injury, Chronic Inflammation, published in Cells (2025) — summary generated from the PubMed abstract.
- 2025
Cells5 citations - Level DAnimal StudyPubMed
Loading tea polyphenols enhances the repair of human umbilical cord mesenchymal stem cell sheet after spinal cord injury.
Animal Study on Spinal Cord Injury, Chronic Wound, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level DLaboratory StudyEurope PMC
Evaluation of the Interaction Between Wharton's Jelly-Derived Mesenchymal Stem Cells and β-Mercaptoethanol
Laboratory Study on Spinal Cord Injury, Neuroinflammation, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus2 citations - Level CProspective StudyEurope PMC
Peripheral Blood-Derived Mesenchymal Stem Cells Promote A2 Phenotype Polarization in Astrocytes via TGF-β-Mediated PI3K/Akt Pathway Activation
Prospective Study on Spinal Cord Injury, Neuroinflammation, published in Eur J Med Res (2025) — summary generated from the PubMed abstract.
- 2025
Eur J Med Res1 citations - Level DAnimal StudyPubMed
The effect of PU/MWCNT nanofiber scaffolds containing hesperidin nanoparticles and mesenchymal stem cells on the microglia and astrocyte phenotype in the spinal cord injury model.
Animal Study on Spinal Cord Injury, Neuroinflammation, published in Neuroscience (2025) — summary generated from the PubMed abstract.
- 2025
Neuroscience2 citations - Level BRandomized Controlled TrialPubMed
Resveratrol pretreatment improved the function of mesenchymal stem cells in the recovery of spinal cord injury by stimulating the secretion of nerve growth factor.
Randomized Controlled Trial on Spinal Cord Injury, published in J Mol Histol (2025) — summary generated from the PubMed abstract.
- 2025
J Mol Histol - Level DAnimal StudyPubMed
Spinal Cord Injury Treatment by Applying a Composite Scaffold Transplanted with Mesenchymal Stem Cells and Chitosan-Coated Nanostructured Lipid Carriers of Curcumin.
Animal Study on Spinal Cord Injury, Chronic Inflammation, published in ACS Appl Bio Mater (2025) — summary generated from the PubMed abstract.
- 2025
ACS Appl Bio Mater - Level DNarrative ReviewEurope PMC
Boosting the Therapeutic Potential of Extracellular Vesicles Derived From Mesenchymal Stem Cells via Advanced Preconditioning for Neurodegenerative Disorders
Narrative Review on Stroke Research, Spinal Cord Injury, Neuroinflammation, Chronic Inflammation, published in Stem Cells Int (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cells Int1 citations - Level DAnimal StudyEurope PMC
Overexpression of miRNA-216 in exosomes derived from umbilical cord mesenchymal stem cells promotes angiogenesis and improves functional recovery after spinal cord injury
Animal Study on Spinal Cord Injury, published in Iran J Basic Med Sci (2025) — summary generated from the PubMed abstract.
- 2025
Iran J Basic Med Sci1 citations - Level DNarrative ReviewEurope PMC
Advancing regenerative therapies with umbilical cord-derived mesenchymal stem cells: A review
Narrative Review on Osteoarthritis, Type 2 Diabetes, Spinal Cord Injury, Immune Modulation, published in Biomol Biomed (2025) — summary generated from the PubMed abstract.
- 2025
Biomol Biomed4 citations - Level BClinical TrialEurope PMC
Mapping the Landscape of Mesenchymal Stem Cell-Derived Extracellular Vesicles: From Bench to Bedside
Clinical Trial on Osteoarthritis, Spinal Cord Injury, Immune Modulation, published in Stem Cells Int (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cells Int - Level BClinical TrialPubMed
Mesenchymal stem cells in neurological disorders: Insights from clinical trials.
Clinical Trial on Stroke Research, Spinal Cord Injury, Neuroinflammation, published in Regen Ther (2025) — summary generated from the PubMed abstract.
- 2025
Regen Ther - Level DAnimal StudyEurope PMC
Exosomes derived from menstrual blood-derived mesenchymal stem cells and treadmill training restore motor function following SCI by activating PI3K/Akt pathway
Animal Study on Spinal Cord Injury, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther1 citations - Level DNarrative ReviewEurope PMC
Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Strategy for Spinal Cord Injury
Narrative Review on Spinal Cord Injury, Neuroinflammation, Scar, Chronic Inflammation, published in Int J Nanomedicine (2025) — summary generated from the PubMed abstract.
- 2025
Int J Nanomedicine2 citations - Level DAnimal StudyPubMed
Therapeutic effectiveness of conditioned medium derived from adipose tissue mesenchymal stem cells and dehydroepiandrosterone in a rat model of spinal cord injury.
Animal Study on Spinal Cord Injury, published in IBRO Neurosci Rep (2025) — summary generated from the PubMed abstract.
- 2025
IBRO Neurosci Rep - Level BClinical TrialPubMed
Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial.
Clinical Trial with a reported sample of 10 on Spinal Cord Injury, published in Nat Commun (2024) — summary generated from the PubMed abstract.
- 2024
- n = 10
Nat Commun75 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406